Results 31 to 40 of about 311,354 (265)
Therapeutic Apheresis and Dialysis, EarlyView.ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo +5 more
wiley +1 more source
ClinicoEconomics and Outcomes Research, 2020 Addisu Bogale Zawudie, 1 Teferi Daba Lemma, 2 Dawit Wolde Daka 2 1Pathfinder International Ethiopia, Addis Ababa, Ethiopia; 2Faculty of Public Health, Department of Health Policy and Management, Jimma University, Jimma, EthiopiaCorrespondence: Dawit ...
Zawudie AB, Lemma TD, Daka DW
doaj
Cost of dementia in Switzerland
Swiss Medical Weekly, 2010 Questions under study: The aim of this study was (a) to estimate the cost of dementia in Switzerland, (b) to compare the average annual cost for people with dementia who live at home and those living in an institution and (c) to analyse how the ...
E Kraft, M Marti, S Werner, H Sommer
doaj +1 more source
BMC Pulmonary Medicine, 2023 Background In Singapore, there is currently scarce population-based research informing the recent trends of asthma-related healthcare burdens. In this study, we investigated the past 25-year trends of asthma-related hospitalisations, emergency department
Laura Huey Mien Lim +3 more
doaj +1 more source
Vestibular Patient Journey: Insights From Vestibular Disorders Association (VeDA) Registry
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Vestibular symptoms impose a high burden of disability. Understanding real‐world diagnostic and treatment pathways can identify care gaps and guide interventions. We aimed to characterize symptom profiles, diagnostic trends, provider involvement, and treatment patterns in vestibular disorders.
Ali Rafati +10 more
wiley +1 more source
ClinicoEconomics and Outcomes Research, 2019 Kevin L Ong,1 Maria Runa,1 Edmund Lau,2 Roy D Altman3 1Biomedical Engineering, Exponent, Inc, Philadelphia, PA, USA; 2Health Sciences, Exponent, Inc, Menlo Park, CA, USA; 3School of Medicine, University of California, Los Angeles, CA, USA Purpose ...
Ong KL, Runa M, Lau E, Altman RD
doaj
Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni +19 more
wiley +1 more source
A cost-of-illness study of spina bifida in Italy
ClinicoEconomics and Outcomes Research, 2013 Giorgio L Colombo,1,2 Sergio Di Matteo,2 Marta Vinci,3 Claudia Gatti,4 Maria Paola Pascali,5 Mario De Gennaro,6 Elena Macrellino,7 Giovanni Mosiello,5 Tiziana Redaelli,7 Francesca Schioppa,7 Cristina Dieci8 1University of Pavia, Department of Drug ...
Colombo GL +10 more
doaj
Estimating the Direct Cost of Cancer in Nepal: A Cross-Sectional Study in a Tertiary Cancer Hospital
Frontiers in Public Health, 2019 Background: The increasing prevalence of cancer and lack of strong health financing system in low income countries like Nepal is exerting an enormous financial burden on cancer patients.
Shiva Ram Khatiwoda +3 more
doaj +1 more source
Childhood cancer.Nonmedical costs of the illness [PDF]
Cancer, 1979 The financial burden of cancer treatment is a major source of anxiety for the families of pediatric cancer patients. Parents of these patients report that nonmedical, out-of-pocket expenditures are the most troublesome because, unlike medical bills, nonmedical costs must be paid immediately and are rarely reimbursed.
S B, Lansky +5 more
openaire +2 more sources